The aim of the present study was to assess the prognostic role of pretreatment PTEN and PTENP1 gene expression levels in patients with locally advanced breast cancer, stratified by TP53 mutations status, and the predictive role of PTEN and PTENP1 gene expression levels toward chemotherapy response. This evidence concerns the gene TP53 and breast cancer.